HISAMITSU PHARMACEUTICAL CO.,INC.JP:4530Income statement

Market cap
¥548.5B
P/E ratio
21.2x
2012/022013/022014/022015/022016/022017/022018/022019/022020/022021/022022/022023/022024/022025/02
Revenue137,794142,772150,635156,743161,852145,925147,870143,408140,992114,510120,193128,330141,706156,006
Revenue growth (%)-
Cost of revenue---57,06358,31953,15555,68854,72753,38845,33750,12655,63062,73564,810
Gross profit---99,680103,53292,77092,18288,68087,60369,17370,06772,69978,97091,196
Gross margin (%)---
Operating margin (%)---
Operating income ---20,52727,73026,30626,34522,27822,72710,6719,33711,59913,16718,895
Operating expenses ---79,15375,80266,46465,83666,40164,87558,50160,73061,09965,80372,300
Income before tax 33,49433,05128,91028,48928,00828,17928,24524,64725,62811,82912,63816,05119,64924,010
Pretax margin (%)24.323.119.218.217.319.319.117.218.210.310.512.513.915.4
Provision for income taxes---10,4319,9939,4438,3676,2947,2442,7643,0933,9874,7546,385
Effective tax rate (%)---
Net income 18,43918,80921,35718,78417,78420,54119,32719,37818,9119,4339,86212,12614,43116,363
Net income margin (%)
Earnings per share215.09219.56249.3219.28208.81241.27228.52230.08227.58113.22118.92148.01181.62295.57
Diluted EPS215.09219.56249.3219.28208.76241.15228.35229.86227.3113.11118.84147.88181.42295.15
Dividend payout ratio (%)--------
Dividend per share--------8383.58484.58590
EBITDA---
EBITDA margin (%)---